AsphaTrainings Program | Free webinars on ATMPs

atmps

AsphaTrainings Program | Free webinars on ATMPs

Tomorrow, Christopher Mann, our Scientific and Regulatory Affairs Associate Director, will hold two free webinars both related to Advanced Therapy Medicinal Products (ATMPs).

The first webinar will start at 3 p.m. and will give you an Introduction to Advanced Therapy Medicinal Products (ATMPs). This webinar is intended for newcomers to the field as well as those with a less specialised background to introduce some of the more general concepts such as what are ATMPs and how they are classified? What do they consist of and how do they work? What kind of disease do they treat and what are the general scientific and ethical issues surrounding their development?

The second webinar will start at 4 p.m. and will be an advanced approach on product development pathways and strategies for commercialisation of ATMPs. In this webinar we will take a closer look at some of the key examples of approved products and give an overview of how they got to market and what specific considerations might apply for two different product models. For each example we will look at some of the regulatory procedures followed, when they were applied and what additional regulatory obstacles they faced or might arise in a theoretical development of a similar product in order to generate some general considerations about the pathways newer products might take to reach the market.

At the end of both webinars, you will have the opportunity to make questions and our expert Christopher will be fully available to answer you in person.

The registration on both webinars is free so do not miss out on this opportunity and register now:

Introduction to Advanced Therapy Medicinal Products (ATMPs): scientific basics and regulatory definitions for newcomers

Product development pathways and strategies for commercialisation of Advanced Therapy Medicinal Products (ATMPs)

Christopher is looking forward to chatting with you tomorrow!

Team-NB recommendations to MD manufacturers and stakeholders
Medical Devices | Guidance documents on clinical investigation and evaluation